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This introductory chapter does not aim at present-
ing an objective historical account on the origins of
the concept of allosteric interactions and of the
subsequent models. Such an attempt would require
the complete elucidation of the rich network of
interactions that existed at the time between the
concerned scientists at the international scale. This
document should better be viewed as an evocation
of personal memories about my contributions to the
work and the anticipated subjective bias. I was then
a modest, though motivated, graduate student
struggling to initiate a new scientific topic in an
environment of scientific giants constantly commu-
nicating—far above my head—with multiple interna-
tional authorities and personal friends. It may
nevertheless bring the unconventional testimony of
a freshman scientist that is not so often considered in
the official history of scientific discoveries.From Marine Biology to Escherichia coli
(1958)
As far as I can remember, since my early age, I
was fascinated by natural history. Adolescent, I owe
to my Biology Professor at the Lycée Montaigne the0022-2836 © 2013 Elsevier Ltd. Open access under CC BY-NC-ND liceinitiative, in 1954 and 1955, to enroll in summer
courses in marine biology at the laboratories of
Arcachon and Banyuls-sur-Mer in the south of
France. They gave me the opportunity to have my
first “physical” contact with the electric discharge of
the Torpedo marmorata fish and to learn about the
work of David Nachmansohn on acetylcholine and
neurotransmission. This initiation had critical impor-
tance in the later evolution of my work. Accepted as
an independent worker in the laboratory of Banyuls-
sur-Mer, my first publications were primarily about a
new species and genius of parasitic copepod that I
discovered in holothurian echinoderms.1 I became
an enthusiast of marine biology. However, thinking
to find a laboratory for a PhD thesis, I decided to
broaden my interests and visited Jean Brachet for a
few weeks in Brussels in the fall of 1958 where I also
attended Christian de Duve's lectures. Inspired by
their philosophy that the solution of the great
problems of biology had ultimately to be found in
elementary biochemical mechanisms, my passion
shifted to the chemistry of early embryonic develop-
ment and, specifically, the activation of the oocyte by
the fertilizing sperm cell. My naïve theory was that
the enzyme activations that follow the entry of the
spermatozoon in the egg were due to a burst of
subcellular particles called lysosomes by Christian
de Duve. Back in Paris, I tried to test this hypothesis.J. Mol. Biol. (2013) 425, 1396–1406nse.
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says, I asked for help from Jacques Monod, whom I
had briefly met by chance. After a seminar that I gave
at the Pasteur Institute on my project, Jacques
Monod suggested that I, in the future, enter his
laboratory as long as I am ready to abandon my
project and work with E. coli. After 3 months of
reflection, I adopted this solution, keeping my
interest in animal biology for the future!
My entry in Jacques Monod's laboratory, at the
beginning of 1959, put me in a rather stressful
position. To improve my experience in biochemistry,
he suggested that I work first on the expression of E.
coli Lac operon genes transferred by François Jacob
into the Salmonella typhimurium genome. As
expected, I did not find any difference between the
two.2 However, this short venture turned out to be an
exceptional training on the basic methods of
molecular biology under the direct supervision of
Jacques Monod.
The Mechanism of Feedback Inhibition
and the Origins of the Word “Allosteric”
(1961)
The moment came, in the spring of 1959, to select
a project for my PhD thesis. Jacques Monod and
François Jacob suggested several research themes,
most of them dealing with their ongoing work on the
operon. They did not suit me. I wanted to have a
more personal and independent project. A particu-
larly original one, mentioned by François Jacob, held
my attention. Edwin Umbarger had shown that, in
certain bacterial biosynthetic pathways, the first
enzyme is inhibited, in an “apparently competitive”
manner, by the end product of the pathway.3 The
issue was to understand the molecular mechanism
of this elementary regulatory operation. This topic
fitted with the spirit of my first theoretical enthusiasm
about enzyme activations following fertilization. I
selected the subject for my thesis. The experimen-
tation was difficult for a beginner and I felt rather
isolated. François Jacob and Jacques Monod were
fully occupied by the construction of the operon
model,4 mentioning en passant that the regulation of
protein biosynthesis they were concerned with was
of primary importance compared to the mechanism
of activity control I was engaged in.
My first idea was that, if a special molecular
device mediated the feedback inhibition by the
enzyme, one should be able to find a way of
identifying its molecular constituents, for instance,
by dissociating in vitro the regulatory interaction
from the catalytic activity. I started with the first
enzyme of the valine pathway—acetolactate syn-
thetase—that Umbarger and Brown5 had shown to
be feedback inhibited by valine and with the help of
E. coli mutant strains identified by François Jacobthat excreted valine and were interpreted as having
an acetolactate synthase no longer feedback
inhibited by valine. This was the first result of its
type but was never published (1959). Acetolactate
synthase was in fact a difficult enzyme to work with
and I decided to switch to L-threonine deaminase
with a closer supervision by Jacques Monod who
made Edwin Umbarger aware of it (June 1959).
First I confirmed Umbarger's in vitro experiments
that L-threonine deaminase was apparently com-
petitively inhibited by L-isoleucine and that it
displayed “bimolecular” cooperative kinetics toward
both the substrate and the feedback inhibitor.3
However, soon I noticed (end of 1959, beginning of
1960) that the sensitivity of enzyme preparations to
L-isoleucine changed with time and progressively
decreased, specifically in the course of purification.
Heating the enzyme up to 55 °C accelerated the
process and resulted in a complete loss of
sensitivity to L-isoleucine, without significant decline
of enzymatic activity. The effect was blocked by the
chelator magnesium titriplex suggesting the impli-
cation of a heavy metal in the process. Moreover, p-
chloromercuribenzoate, a commonly used reagent
of –SH groups, gave a similar effect in the absence
of heat treatment. Interestingly, the loss of L-
isoleucine feedback regulation was also accompa-
nied by the abolition of the unusual “bimolecular”
kinetics of the enzyme toward its substrate. The
complex cooperative kinetics of the enzyme thus
seemed to be an integral part of the regulatory
properties of the enzyme.
In the spring of 1961, I was invited as a discussant
to the 26th Cold Spring Harbor Symposium on
Quantitative Biology entitled Cellular Regulatory
Mechanisms (1961). Jacque Monod pressed me to
write, by myself, the paper I would read in my oral
communication.6 I first wrote a presentation of the
data and the kinetic paradox they raised. Then I
briefly discussed the two plausible models that might
account for the “apparent competitive” antagonism
between the feedback inhibitor L-isoleucine and the
substrate L-threonine (Fig. 1). According to the first
model, the binding sites for the substrate and
regulatory inhibitor are partially “overlapping” and
the interaction is thus a classic competition by steric
hindrance. In the second, “new”, model referred to as
“no overlapping”, the two sites are separated from
each other and the interaction between ligands takes
place between topographically distinct sites. I
favored the second model that the substrate and
the regulatory effector were to bind topographically
distinct sites particularly on the basis of the argument
that loss of feedback inhibition was accompanied by
a normalization of the kinetics.6 I wrote in my
communication “it seems inevitable to assume the
existence of two distinct sites which we would
respectively designate as activity site (A) and
inhibition site (I) and to further assume that the
Fig. 1. The two plausible models proposed for the
“apparent competitive” antagonism between the feedback
inhibitor L-isoleucine and the substrate L-threonine on L-
threonine deaminase (from Changeux).6
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compound bound at the inhibition site”.
I had the opportunity to show a first draft of the
paper to Jacques Monod and to discuss with him the
relationship between the non-hyperbolic shape of
the substrate saturation curve and the inhibition by
regulatory ligand. According to him, the partial
structural analogy between threonine and isoleucine
(both are amino acids) would allow the substrate to
bind non-specifically to the site of the inhibitor and
vice versa. In other words, a one substrate–one
regulatory site monomer would suffice. I was not
pleased with this scheme that, to some extent,
attenuated the principal message of my findings.
However, I did not feel confident enough to defend
the alternative simple model I had in mind (two active
sites and two regulatory sites) against the views of
my respected and, to some extent, feared supervi-
sor. In any case, this was, in my opinion, an
important moment in the dialog with Jacques
Monod whose views subsequently evolved possibly
as a consequence of personal exchanges with me
and also with Arthur Pardee who briefly visited the
laboratory before the meeting.
At the end of the conference, Jacques Monod
presented orally the General Conclusions of the
Symposium. In the section dealing with the regula-
tion of enzyme activity, he reported my results and
mentioned that “closely similar observations have
been made independently and simultaneously by
Pardee (private communication) on aspartate car-
bamyl transferase” (see Ref. 7). He did not use orally
the word allosteric but instead “Novick-Szilard-
Umbarger” effect that emphasized the cybernetics
of the feedback inhibition process. Yet, his presen-
tation showed a full appreciation of the novelty andgenerality of the concept of an interaction between
topographically distinct and stereospecific sites.
These General Conclusions were an important
moment of the meeting where Jacques Monod
displayed his exceptional ability to brilliantly synthe-
size current ideas into organized concepts. Only in
Monod and Jacob's subsequently written publication
of the Conclusions does the word “allosteric”
appears as composed of two Greek roots expressing
the difference (αλλο–) in (στερεο–) specificity of the
two binding sites to qualify and generalize the “no
overlapping sites”mechanism and its mediation by a
conformational change of the protein.8 This was the
birth date of the word allosteric. The appearance of
the word also consolidates, in the written text, the
shift of emphasis from the cybernetics of feedback
inhibition to the more molecular and biochemical
aspects of allosteric interactions. With the work on
the operon being completed with this 26th Cold
Spring Harbor meeting, the reflection on allosteric
proteins became progressively a privileged topic in
Jacob and Monod scientific interests.The Concept of Allosteric Transition and
Koshland Induced Fit (1963)
Both in the reference list of my written communi-
cation (p. 318) and in Monod and Jacob printed
conclusions (p. 391), the name of Daniel Koshland
appears and the “induced-fit” theory suggested to
account for the indirect interaction between distinct
sites. Yet, initially, Koshland's theory did not address
the regulation of enzyme activity by a metabolic
signal but the specificity of enzyme catalysis. His
view was that the enzymatic reaction occurs “only
after a change in shape of the enzyme molecule had
been induced by the substrate”.9
Our contribution was to extend and generalize
Koshland idea on enzyme catalysis to the indirect
allosteric interaction between active site and regu-
latory site that would then be mediated by a
reversible conformational change of the enzyme
“induced” by the ligand. In other words, the local
catalytic process was extended to the global signal
transduction mechanism mediated by the protein.
This was the origin of the concepts of allosteric
interaction and allosteric transition that have, since
then, been broadly applied not only to regulatory
proteins in general but also to the mode of action of
pharmacological agents (see Refs. 10 and 11).
My research on the properties of L-threonine
deaminase was developing in parallel with the work
from different laboratories, for instance, on aspartate
transcarbamylase (ATCase),7 eukaryotic glutamic
dehydrogenase,12–16 acetyl-CoA carboxylase17 and
phosphorylase b,18 among many others. The data
collected substantiated the initial proposal of distinct
sites for substrate and regulatory ligand. François
1399Perspective: Origins of AllosteryJacob and Jacques Monod became more and more
concerned by the reflections on allosteric sites and
interactions, to the extent that they decided to write,
together with me, a general review entitled “Allosteric
proteins and cellular control systems”.19 Its aim was
to further specify the definition of the word “allosteric”
on the basis of the available data and to introduce, as
we shall see, an important issue about the molecular
regulation of the newborn operon. Concerning the
specification of the concept of allostery, the evidence
that the allosteric effectors do not directly participate
in the reaction they control was emphasized. In
addition, on the basis of observations such as the
activation of phosphorylase b by 5′ AMP18 and of
glutamate dehydrogenase by various effectors
(ADP, diethylstilbestrol),20 a change in the state of
aggregation of the protein was proposed, among
others, as a plausible mechanism for the allosteric
transition. Yet, the question was raised as to whether
or not “this alteration is induced directly by the binding
of the nucleotide, the dimerisation being then a result
of this primary effect” (p. 319). Still, in the general
discussion, the “induced-fit” theory of Koshland is
suggested (p. 323) as contributing to the allosteric
transition. Moreover, I was personally not pleased by
the emphasis on a change of the state of aggregation
associated with ligand binding, enthusiastically
defended by Gordon Tomkins and others. During
1962 and in the spring of 1963, I tried to experimen-
tally test this possibility with L-threonine deaminase. I
found repeatedly that the sedimentation coefficient of
the enzyme did not change in the presence of either
the substrate or the allosteric effectors and remained
close to 8.6 s.21 This was confirmed in the laboratory
by the ongoing work of Agnes Ullmann and Roy
Vagelos on phosphorylase b.22 For the time being,
we had to think about a general mechanism of
allosteric transition that would not involve a change of
aggregation.21,23
At the end of my first public presentation at the
1961 Cold Spring Harbor meeting, Bernard Davis
stood up and noted the analogy between the
cooperative binding properties of L-threonine deam-
inase and oxygen binding to hemoglobin. This was a
highly relevant comment and, for me, the beginning
of an exciting story, even though generations of most
distinguished scientists including Linus Pauling,
Jeffries Wyman and others had being producing
major contributions to it in the past 50 years. Max
Perutz's structural work on hemoglobin had recently
made major progress. In the 1963 review, it was
mentioned that “the four haem groups are actually
wide apart (40A) excluding any possibility of direct
interaction”24 and that “the recent crystallographic
work of Muirhead and Perutz (personal communica-
tion) has indicated that the distance between certain
–SH residues in the molecule may be shifted by
about 19% upon oxygenation, providing direct
though still tentative evidence of a conformationalalteration” (p 320). At the end of 1962, I had the
privilege to meet for the first time Max Perutz whom I
invited for a lecture in Paris as secretary of the “Club
de Biologie Moléculaire”. I remember very well the
dinner discussion with his wife at the restaurant “La
pie qui chante”, which followed his talk. He was
interested by the idea of allosteric interaction and
was aware of my recent data on threonine deami-
nase…In this context, he was amazed that at 5.5 Å
resolution “only the quaternary structure of hemo-
globin did change upon oxygenation”. This was
remarkable. I argued that these data were consistent
with our views but that “the tertiary structure of the
globin chain must also change upon oxygen
binding…”. The mention of these results in the
1963 review emphasized our early interest in the
relationship between subunits' tertiary conformation
and the quaternary structure of regulatory proteins.
However, they were further specified only in the
subsequent 1965 model.
The 1963 review ends with an attempt to extend
the concept of allosteric proteins to both hormone
action (thyroxine and estrogens) and gene repres-
sors “possessing two sites, one of which binds the
operator, the other the (positive or negative) effector”
(p. 328). In 1961, Jacob and Monod had published
that the repressor was a polyribonucleotide. Howev-
er, as a result of the development of the work on
regulatory enzymes in the laboratory, the analogies
with the repressor binding properties, the failure to
identify the repressor as a RNA and other observa-
tions, including the possible protein nature of lambda
repressor,25 the idea was abandoned. It was evident
that the main reason to write the 1963 review was for
François Jacob to abandon the RNA hypothesis and
to propose that gene repressors were bona fide
allosteric proteins.
Meanwhile, my thesis work was further progres-
sing. Among the many observations, new ligands of
L-threonine deaminase were discovered, which, for
instance, bind to the regulatory site but stabilize the
active conformation (valine, norleucine and the
substrate analog L-allothreonine) instead of shutting
it off (1962), and chemical conditions (some revers-
ibly similar to pH) that uncouple regulatory and active
site and abolish cooperative interactions were
further specified (1963). Yet, at variance with
Gerhart and Pardee,7,26 the protein did not split
into subunits as a consequence of uncoupling. Also,
mutations that differently alter the response to
regulatory ligands were uncovered (some had lost
their sensitivity to isoleucine, others have increased
it, some had degrees of cooperation between
regulatory sites altered and their interaction with
the active sites and so on).21
At the end of 1963, beginning 1964, I began to write
down and organize all the data I had collected for my
thesis. It took me several months of considerable
efforts, fearing too many criticisms frommy respected
1400 Perspective: Origins of Allosteryand severe advisor. Last, following my “innate”
tendency to build theories, I wanted to end my thesis
by a mathematical model that would globally account
for all the observations I had made. In particular, I
wanted to account for the well-defined relationships
between homotropic and heterotropic interactions
also noted with several other systems, on the basis
of simple structural principles. I discussed the topic
with Adam Képès, an outstanding specialist in
enzyme kinetics working in the laboratory. The result
came soon yet in the format of huge equations that I
found extremely difficult to use even if based upon
simple Michaelis–Menten principles. Later (mid
1964), I handed Jacques Monod the first typed
version of my thesis work23 and mentioned to him
the difficulties I had encountered. He was especially
interested with my data and even more with the
theoretical challenge I had raised.The MWC Model (1965)
As a consequence of this encounter, daily lively
debates with Jacques Monod followed. I specially
appreciated these privileged moments. Facing the
whiteboard, I reviewed for him, in a systematic
manner, the available data. In particular, I came
back to observations I had made about the effect of
urea (1962), which, at an adequate concentration,
inactivates reversibly threonine deaminase, an
inactivation interpreted as a split of the enzyme
into subunits (Fig. 2). Quite interestingly, in this
system, the allosteric activators (such as L-norleu-Fig. 2. Opposite effects of activators and inhibitors on
the inactivation of L-threonine deaminase in the presence
of urea (from Changeux).21cine, L-valine and L-allothreonine) facilitated inacti-
vation and thus subunit dissociation while the
feedback inhibitors (such as L-isoleucine) protected
against inactivation and thus strengthened the
assembly of the subunits in the protein. In the
communication I presented to the 1963 Cold Spring
Harbor meeting, I even “surmised that the allosteric
transitions involve weakening or increasing interac-
tions between subunits. Such a situation is actually
known in the case of hemoglobins (p. 503)”21 (see
Ref. 27). Continuing on the discussions with
Jacques Monod, to formally account for the ob-
served effects, I mentioned the possibility of “three”
possible conformational states, one for each exper-
imental condition (presence of activator, presence
of inhibitor and no effector). Then, Jacques Monod
with his reductionist mind pressed me, as usual, to
limit the number of hypotheses. Two states should
suffice! I immediately agreed and further documen-
ted the virtues of the “two states” with a tight (to
become T) or relaxed (to become R) mode of
packing the subunits, having different intrinsic
affinities for both substrate and allosteric effectors.
This would altogether account for the signal
transduction mechanism and the relationships
between homotropic and heterotropic interactions.
This is, to my opinion, the birth date of the “two-state
mechanism” of pre-existing conformational states
(R ↔ T) and, by consequence, of a “selective” rather
than an “instructive” effect of the ligands. It allowed
a remarkable economy of means and explained
simply a large number of kinetic properties of the
native enzyme that we progressively discovered
during the following months. All this was far from
any deep theoretical consideration…just for sake of
simplicity! These views led, after many writings and
re-writings,28 to the 1965 MWC (Monod–Wyman–
Changeux) model.29 In parallel, I had the respon-
sibility to compose (and often re-compose) nearly all
of the figures. For me, this “quasi-artistic” activity
was a most enjoyable responsibility that Jacques
Monod himself quite surprisingly was reluctant to
take. The final version was handed by Jacques
Monod directly to Sydney Brenner and Francis Crick
in Cambridge and readily accepted. MWC state-
ments have been since then abundantly re-formu-
lated and discussed in terms of “conformational
shift” or “shape shifting” by various groups.30–34
An important part of the final version of the MWC
paper deals with the quaternary organization of
proteins and specifically with their symmetry prop-
erties. It developed mainly not only from the personal
reflections of Jacques Monod about the three-
dimensional organization of proteins in relation with
genetic complementation but also from abundant
exchanges, with Francis Crick and Jeffries Wyman
(among others), but that usually—and unfortunately—
did not involve me as a participant. Yet, I fully
appreciated the issue and became much concerned
1401Perspective: Origins of Allosteryby the oligomeric status of most well-identified
regulatory proteins (even if a few exceptions do
exist).33,34 The final version of the manuscript included
at the end a section about thermodynamic consider-
ations on symmetry that I found far from my way of
thinking. The versions of the model that were
introduced in my PhD thesis or that I presented by
myself at the 1964 Brookhaven symposium did not
include an extensive discussion on the quaternary
organization of proteins. However, both mentioned
what I considered the fundamental mechanistic issue
of the model: the cooperative symmetrical assembly of
the subunits within an allosteric oligomer and the
quaternary constraint established between subunits
that affect their tertiary organization yielding an all-or-
none molecular switch as the structural mechanism of
the cooperative effect of ligands binding.
The model postulates the following:
(1) regulatory proteins are symmetrically orga-
nized from a small number of subunits
associated into a cooperative structure form-
ing closed “microcrystals”, or oligomers, and
the tertiary organization of the individual
subunits is constrained within the oligomer
by its quaternary organization;
(2) protein oligomers exist in a few discrete
conformations (R, T,…) in thermal equilibrium
in the absence of a regulatory signal;
(3) the regulatory ligands merely shift the equi-
librium between the conformations, selective-
ly stabilizing the one for which they display the
highest affinity; and
(4) the conformational transitions take place in an
all-or-none concerted fashion for all subunits
and thus with conservation of symmetry.
Writing the basic expression of the model was
started together with Jacques Monod. In the ab-
sence of ligand, the two states, R0 and T0, were
assumed to spontaneously establish an equilibrium
characterized by an intrinsic equilibrium constant,L0 = T0/R0, called the allosteric constant. The
ligands would differentially bind to each state with
microscopic dissociation constants, KR and KT, that
“are the same for all homologous sites in each of the
two states” independent of their ligand occupancy
and with c = KR/KT. The development of the formal-
ism was continued by Jacques Monod himself.
However, the final, correct, version of the equations
was derived by Robert Baldwin who was present for
a sabbatical at the Pasteur Institute.
The model fundamentally distinguishes a “function
of state”, “R”, which describes the conformational
equilibrium, and a “binding function”, “Y”, which
distinctly evolves as a function of ligand concentra-
tion. The signal transduction mechanism then results
exclusively from the displacement, or conformational
shift, of the spontaneous equilibrium between the R
and T states, including the observed cooperativity
between sites.
A year following the MWC publication, Koshland,
Nemethy and Filmer, reactualizing the Pauling
scheme for O2 cooperativity in hemoglobin,
35
proposed an alternative instructive [KNF (Kosh-
land–Nemethy–Filmer)] model36 that implies a grad-
ed “induced” change of biophysical parameters and
the superimposition of the “state” and “binding”
functions. The debate is still lively today.33,34,37Testing the MWC Model
The first molecule with which the model could be
tested was, of course, hemoglobin. During my
military service, I had the opportunity to establish
friendly relationships with another draftee François
Bernède who was doing sophisticated computations
on the military supercomputers. He tried to fit the O2
binding curves of horse hemoglobin by R. Lyster with
the MWC model. The fit was remarkable with
plausible values of the MWC parameters (L = 9054
and c = 0.014) to the extent that the figure was
integrated as Fig. 3 in the final version of the paper.Fig. 3. Lattice and oligomeric
models for cooperative interactions
between receptor units in a biolog-
ical membrane (from Changeux).38
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attempts by Edelstein,39 Perutz et al.,40 Hammes
et al.,32 Fischer et al.41 and Viappiani et al.42 to
confront hemoglobin data with the respective pre-
dictions of the MWC versus KNF model.
In 1965, liberated from my military obligations, I
decided to further challenge the MWC model by
myself outside the Pasteur environment. I took a
postdoctoral position with John Gerhart and Howard
Schachman, in Berkeley's Molecular Biology Virus
Laboratory, who had in hands large amounts of highly
purifiedATCase. I had inmind to test one of the crucial
propositions of the MWC model that the conforma-
tional equilibrium of the protein becomes established
independently of the binding of the ligand. In other
words, the state function R should differ from the
binding function Y. The binding experiments I did with
ATCase together with the conformational data col-
lected by Gerhart and Schachman demonstrated that
this was the case.43,44
Yet, to fit the data with the original MWC equations,
Merry Rubin, a student of Howard specially compe-
tent in computational sciences, helped me to extend
the model to the general situation where regulatory
ligands nonexclusively bind to both R and T states
(the case of nonexclusive binding of the substratewas
present in the original model) and the consequences
on the cooperativity and shift of the R–T equilibrium.
The paper was accepted by Sydney Brenner for the
Journal of Molecular Biology,45 and similar findings
were also reported with phosphofructokinase.46 The
general formulation it proposes has two important
consequences:
(a) the new equations adequately fit the ATCase
data despite an uncertainty on the number of
sites per ATCase molecule (six rather than
four as initially thought), with the substrate
analog succinate almost exclusively bound to
the R state (c b 0.001), while the feedback
inhibitor CTP is nonexclusively bound (1.7-
fold stronger) to the T state, and with L = T/
R = 4; the data unambiguously demonstrate
the anticipated distinction between the state
and binding function.44,45
(b) the generalization of nonexclusive binding
offers a plausible (among others) mechanism
for partial agonism, an important issue in
pharmacology (see Refs. 10 and 47).
In the past 50 years, the MWC model has led to
considerable structural and biophysical work on the
conformational transitions of a large spectrum of
regulatory proteins. It has been recently re-exam-
ined in the framework of molecular dynamics48–51
and contrasted again with the sequential induced-fit
scheme, in particular, for hemoglobin41,52 (for
review, see Ref. 34).Extension to Membrane Assemblies:
A Subunit-Based General Model for
Cooperative Interactions
In the conclusion of my thesis (1964), 23 I
considered explicitly the possibility of extending the
MWC model to the “membrane phenomena involved
in the recognition of communication signals and their
transmission (synaptic transmission, for example)”.
Before leaving Pasteur, I decided to challenge the
plausible extension of the model to brain proteins
involved in synaptic transmission. I had been
acquainted with acetylcholinesterase (AChE) and
Torpedo electric organ during my early experience in
Arcachon. In the absence of a well-identified
neurotransmitter receptor, I decided to investigate
the kinetic properties of AChE taking benefit of the
many compounds left by Daniel Bovet when he was
working at the Pasteur Institute (in particular, de-
rivatives of flaxedil, the first synthetic curare he
discovered). Interestingly, some of these com-
pounds did not behave as steric competitors but as
allosteric modulators of AChE activity suggesting a
possible (though only superficial) analogy with the
authentic receptor.53
In the spring of 1966 while in Berkeley working
with Howard Schachman, I received a letter from
Max Delbrück, who, aware of my thesis work, invited
me to give a series of three lectures at Caltech on
allostery, the last one mentioning cooperativity in
membrane proteins. Inspired by 1963 Peter Weiss'
play Marat/Sade, Max amazingly introduced my
lectures as being “the persecution and assassina-
tion of ‘Jean-Paul’ Changeux as performed by the
inmates…”. The lectures and the questions went
quite well. Commenting my last lecture, Max was
struck by a slide I showed where nearest-neighbor
cooperative interactions between receptor mole-
cules were suggested to take place in a membrane.
I said that I wanted to develop a mathematical
model of such interaction, but he mentioned that he
was personally interested by the project. He
nevertheless suggested that I meet the solid-state
physicist Charles Kittel when back in Berkeley. The
relationship with Kittel was extremely positive, and
together with one of his students and a friend Jean
Thiéry, the MWC model was re-examined and re-
formulated54 (Fig. 3). In addition to the classical
oligomeric case of membrane receptors, the model
was applied to larger—unlimited—cooperative as-
semblies of membranes proteins, in a two-dimen-
sional lattice54 (Fig. 3). At variance with MWC, the
thermodynamic formulation was based on the
conformational transition of single units (or proto-
mers) between a minimum of two states modulated
(or not) by the interaction with other protomers with
the isomerization constant: (s)/(r) = l′. Several for-
mulations were proposed.
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as the Weiss molecular field approximation), in a
system of interacting protomers, for instance, within
a membrane lattice, the free energy F of the
transition (s ↔ r) is proposed to depend on the
fraction of protomers that are already in the r state
and expressed as ΔF = (ε − η(r)).
The isomerization constant l′ = (s)/(r) is then
simply l′ = exp[βΔF] = lΛ (r).
Depending on the value of the free energy of the
interaction between protomers, the model predicts
the existence of various classes of responses to
specific regulatory signals exhibited by biological
systems: from a graded response of a single-
receptor protomer or oligomeric receptor (MWC
model) to an all-or-none phase transition response
in large and periodic protein assemblies.
In more general terms, the model by Changeux
et al.54 lays the groundwork for a general and simple
thermodynamic mechanism of conformational se-
lection (see Refs. 34, 37 and 42). Independently, a
general formulation covering both MWC and KNF for
oligomers was presented by Eigen.55 As in Chan-
geux et al.,54 the induced-fit KNF model appears as
a limit case in which the unbound active R0 state of
MWC is simply omitted.30–32
The lattice model was rediscovered and further
developed—30 years later—by Dennis Bray and
colleagues with the experimental system of bacterial
chemoreceptors.56,57 Yet, no such cooperative
interaction has ever been identified in a native
synaptic membrane…but other supramolecular as-
sembliesmight possibly be interpreted in those terms
from the chaperonins to flagellar motion and even the
gene transcription complex! (see Refs. 34 and 58).
Conclusion: The Nicotinic Acetylcholine
Receptor, Allosteric Modulation and
Drug Design
I deliberately close this chapter on the “Origins of
allostery” with the Changeux et al. model.54 It has
been a concrete stimulus for decades of research I
subsequently did on membrane receptors. The
moment had come for me to experimentally test the
suggestion from my PhD thesis (1964) that allosteric
mechanismsmight operate in the nervous systemand
specifically mediate synaptic transmission. The early
work I did on acetylcholine esterase from Torpedo in
1965,53 before I left to the US, convinced me that, to
be efficient, the work had to be done on a real
receptor. However, at that time, no authentic receptor
for a neurotransmitter had ever been identified. I thus
decided to leave Berkeley (February 1967) for a
second postdoctoral study with David Nachmansohn
at Columbia University, in New York, then world
expert on the chemistry of cholinergic systems from
electric fishes. I wanted to train myself in thedissection and recording of the electrophysiological
response of the single electroplaque from Electroph-
orus electricus electric organ to nicotinic agents with
the ultimate aim to establish a rigorous strategy linking
the in vivo physiological and pharmacological re-
sponse to the chemistry of the receptormolecule I was
planning to identify from the electric organs, an
extremely rich source of nicotinic synapses.
I stayed only a few but very productive months with
David and returned to the Pasteur Institute at the end of
1967. There I established the electroplaque setup. A
fundamental step in the strategy thenbecame to reduce
the electroplaque system to the subcellular and last
molecular levels without losing its characteristic phys-
iology and pharmacology. Having practiced with my
hands the assay of bacterial permeases, I developed,
together with Michiki Kasai, an in vitro system of
excitable membranes or “microsacs” from the electric
organ that responded to acetylcholine in amanner very
similar to that recordedwith the electroplaque.59,60 This
step was essential to me since it demonstrated
unambiguously that the regulatory interactionmediating
channel opening operates in the absence of energy
source, in a chemically defined environment. It was a
strong suggestion in favor of an allosteric transition of
the receptor. It also paved the way to the chemical
identification of the receptor protein from these
membranes,61 using nicotinic ligands in conjunction
with a snake venom toxin α-bungarotoxin.62 Bungar-
otoxin blocked, altogether, the physiological response
to nicotinic agonist on the electroplaque in vivo and on
the microsacs in vitro and also bound decamethonium
to a protein isolated from these membranes.61 All
subsequent molecular biology and biophysical work
has confirmed that this protein is bona fide the nicotinic
acetylcholine receptor protein.34,63
The nicotinic receptor became a favorite model of
the subsequently identified pentameric, tetrameric or
trimeric, often hetero-oligomeric, ligand-gated ion
channels, including the GABA receptor63–65 and
even G-protein-coupled receptors.34,66 When the
genomic analysis of Tasneem et al. that sequences
homologous to the nicotinic receptor were present in
bacteria appeared,67 I heartily encouraged Pierre-
Jean Corringer to functionally express as a ligand-
gated ion channel and purify one of these
molecules.68 His success opened the field to the
X-ray crystallography of pentameric receptors69–71
and their conformational transitions.69,72,73 After
reaching the brain, I was back to prokaryotes!
The presently available data are consistent with
the notion that the pentameric receptors, including
the nicotinic receptor, behave as authentic allosteric
proteins yet with features of their own. They
demonstrate, in particular, the following74,75:
(1) an oligomeric pentameric organization with an
axis of symmetry (or pseudosymmetry) per-
pendicular to the plane of the membrane;
1404 Perspective: Origins of Allostery(2) a topological distinction between the neuro-
transmitter (ACh) sites (distant by 40 Å be-
tween ACh sites) in the extracellular domain
and the ion channel (distant by 60 Å from the
ACh sites) in the transmembrane domain,
demonstrating that the interaction between
the neurotransmitter (ACh) and the channel is
an indirect—allosteric—interaction;
(3) the occurrence of several discrete conforma-
tional changes (in general, more than two)
mediating activation (channel opening) and
desensitization (slow inactivation toward a
high-affinity state); and
(4) the presence of multiple allosteric “modulatory
sites” in the synaptic (e.g., Ca2+) and trans-
membrane domain (e.g., ivermectin, general
anesthetics,…).
Further, the allosteric transition paradigm adds a
new dimension to receptor understanding, signal
transduction and drug design, in particular, with the
concept of “allosteric modulator”,11 which is abun-
dantly used with ligand-gated ion channels,76–79 G-
protein-coupled receptors66,80 or tyrosine kinase
receptors,81,82 among many regulatory proteins. In
the classical pharmacology paradigm, both agonist
and antagonist drugs were designed to fit a site
present on a unique receptor conformation. By
contrast, the allosteric scheme posits that agonists
and antagonists, as well as positive and negative
allosteric modulators, select and stabilize several
structurally different conformations, each with its own
pharmacological specificity. Many new openings for
drug design are thus emerging from this new and
simple approach fueled by the abundant structural and
molecular dynamics studies that emerged from the
broaddiversity of recently discoveredneurotransmitter
receptors, following the lead of the nicotinic receptor.
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